Key result
Zio Patch linked to ~72% higher AF detection compared to a 24-hour Holter monitor.
Why the study?
Does the Zio Patch improve the detection of atrial fibrillation and other arrhythmias compared to a 24-hour Holter monitor in patients with paroxysmal atrial fibrillation?
Observational (n=74)
Single-blind
No
Does the Zio Patch improve the detection of atrial fibrillation and other arrhythmias compared to a 24-hour Holter monitor in patients with paroxysmal atrial fibrillation?
Extended continuous ambulatory monitoring with the Zio Patch significantly improved the detection of atrial fibrillation and other arrhythmias compared to a standard 24-hour Holter, leading to meaningful changes in clinical management in over a quarter of patients.
Answers are grounded in this paper and cite their sources.
Extended monitoring may enhance AF detection in paroxysmal cases; leaves open whether it improves clinical outcomes.
BACKGROUND: Outpatient ambulatory cardiac rhythm monitoring is a routine part of the management of patients with paroxysmal atrial fibrillation (AF). Current systems are limited by patient convenience and practicality. METHODS: We compared the Zio(®) Patch, a single-use, noninvasive waterproof long-term continuous monitoring patch, with a 24-hour Holter monitor in 74 consecutive patients with paroxysmal AF referred for Holter monitoring for detection of arrhythmias. RESULTS: The Zio(®) Patch was well tolerated, with a mean monitoring period of 10.8 ± 2.8 days (range 4-14 days). Over a 24-hour period, there was excellent agreement between the Zio(®) Patch and Holter for identifying AF events and estimating AF burden. Although there was no difference in AF burden estimated by the Zio(®) Patch and the Holter monitor, AF events were identified in 18 additional individuals, and the documented pattern of AF (persistent or paroxysmal) changed in 21 patients after Zio(®) Patch monitoring. Other clinically relevant cardiac events recorded on the Zio(®) Patch after the first 24 hours of monitoring, including symptomatic ventricular pauses, prompted referrals for pacemaker placement or changes in medications. As a result of the findings from the Zio(®) Patch, 28.4% of patients had a change in their clinical management. CONCLUSIONS: The Zio(®) Patch was well tolerated, and allowed significantly longer continuous monitoring than a Holter, resulting in an improvement in clinical accuracy, the detection of potentially malignant arrhythmias, and a meaningful change in clinical management. Further studies are necessary to examine the long-term impact of the use of the Zio(®) Patch in AF management.
No takes yet. Share an insight, caveat, or question.
Rosenberg et al. (2012) conducted an observational in Paroxysmal atrial fibrillation (n=74). Zio Patch vs. 24-hour Holter monitor was evaluated on Detection of atrial fibrillation episodes (p=<0.0001). The Zio Patch allowed longer continuous monitoring than a 24-hour Holter, detecting atrial fibrillation in 18 additional patients and prompting a change in clinical management in 28.4% of patients.
Synapse has enriched 10 related papers. Consider them for comparative context: